FRET Substrates for COVID-19 Vaccine Development

Written by: Dr. Balint Földesi

Share post on social media:
FRET Substrates for COVID-19 Vaccine Development

Proteases play essential roles in protein activation, cell regulation and cell signaling, as well as, in the generation of amino acids for protein synthesis or utilization in other metabolic pathways. The inhibition of viral proteases necessary for proteolytic processing of polyproteins has been a successful strategy in the treatment of human immunodeficiency virus (HIV) and hepatitis C respectively, proving the potential of protease inhibitors for the treatment of viral infections. Similarly, the main protease of SARS-CoV-2 (Mpro or 3CLpro) is thought to be essential for viral gene expression and replication and, therefore, is regarded as a major target for anti-CoV drug design. AAT Bioquest offers a variety of dark-FRET peptide substrates and fluorogenic substrates which can be effectively used to screen for inhibitors of coronavirus proteases, papain-like proteases and more.

Covidyte™ COVID-19 Substrates

Covidyte™ dark-FRET peptide substrates are robust high throughput screening tools for determining inhibitors of coronavirus proteases. Covidyte™ substrates contain either an 11 or 14 amino acid sequence that can be cleaved by coronavirus proteases. Modified to the terminal ends of each amino acid sequence is a fluorescent donor and non-fluorescent quencher dye. In its intact conformation, substrate fluorescence is quenched by the two dyes being in close proximity of one another. When the internally quenched Covidyte™ substrate is hydrolyzed by coronavirus proteases, a highly fluorescent peptide fragment is produced, and the fluorescence increase is proportional to the coronavirus proteases activity.

Covipyte™ COVID-19 Substrates

The Covipyte™ EN450 dark-FRET peptide substrate contains a 9 amino acid sequence (RELNGGAPI) specific for coronavirus papain-like proteases (PLpro). Conjugated to the N- and C-terminals, respectively, are an Edans donor molecule and a Dabcyl quencher molecule. In its intact conformation, substrate fluorescence is quenched by the donor and quencher molecule being in close proximity of one another. When hydrolyzed by coronavirus PLpro, a highly fluorescent Edans fragment is produced and the fluorescence increase is proportional to the coronavirus proteases activity making it a convenient tool for screening and studying the kinetics of PLpro inhibitors. PLpro of coronaviruses carries out proteolytic maturation of non-structural proteins that play a role in replication of the virus and performs deubiquitination of host cell factors to scuttle antiviral responses.

Dark-FRET Peptide Substrates for Studying Coronavirus Protease Activity

Product Length AA Sequence Target Ex (nm) Em (nm) ε1 Size
Covidyte™ EN450 14 AA KTSAVLQSGFRKME Coronavirus proteases 336 445 5900 100 tests
Covidyte™ EN450 14 AA KTSAVLQSGFRKME Coronavirus proteases 336 445 5900 1000 tests
Covidyte™ ED450 12 AA VNSTLQSGLRKM Coronavirus proteases 336 445 5900 100 tests
Covidyte™ ED450 12 AA VNSTLQSGLRKM Coronavirus proteases 336 445 5900 1000 tests
Covidyte™ TF670 14 AA KTSAVLQSGFRKME Coronavirus proteases 649 664 250,000 100 tests
Covidyte™ TF670 14 AA KTSAVLQSGFRKME Coronavirus proteases 649 664 250,000 1000 tests
Covidyte™ IF670 12 AA VNSTLQSGLRKM Coronavirus proteases 656 670 250,000 100 tests
Covidyte™ IF670 12 AA VNSTLQSGLRKM Coronavirus proteases 656 670 250,000 1000 tests
Covipyte™ EN450 9 AA RELNGGAPI Papain-like proteases 336 445 5900 100 tests
Covipyte™ EN450 9 AA RELNGGAPI Papain-like proteases 336 445 5900 1000 tests

Products From AAT Bioquest

You might also like...

SEE MORE BLOGPOST
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
On August 25, 2006 Cell published Kazutoshi Takahashi and Shinya Yamanaka's work on the induction of pluripotency in embryonic and adult...
DiMPro™ Full-length Transmembrane Proteins from DIMA Biotechnology
DiMPro™ Full-length Transmembrane Proteins from DIMA Biotechnology
Original Article by DIMA Biotechnology
Creutzfeld Jacob Disease and BSE
Creutzfeld Jacob Disease and BSE
On March 20, 1996, the government of the United Kingdom first announced the possible connection between the bovine spongiform...